Войти в систему Зарегистрироваться бесплатно

Akari Therapeutics Plc Операционная прибыль

Что обозначает Операционная прибыль в Akari Therapeutics Plc?

Операционная прибыль Akari Therapeutics Plc является 0.00%

Какое определение для Операционная прибыль?



Показатель относительной доходности компании - это отношение операционной прибыли, деленной на чистую выручку и выраженной в процентах.

Operating margin is an indicator of profitability and is often used to compare the profitability of companies and industries of differing sizes. Companies are collections of projects and markets, individual areas can be judged on how successful they are at adding to the corporate net profit. Not all projects are of equal size, however, and one way to adjust for size is to divide the profit by sales revenue. The resulting ratio is the percentage of sales revenue that gets 'returned' to the company as net profits after all the related costs of the activity are deducted.

Операционная прибыль компаний в Health Care сектор на NASDAQ по сравнению с Akari Therapeutics Plc

Что делает Akari Therapeutics Plc?

akari is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics to treat orphan autoimmune and inflammatory diseases. akari’s lead drug, coversin, a second-generation and potentially best-in-class complement inhibitor, acts on complement component-c5, preventing release of c5a and formation of c5b – 9 (also known as the membrane attack complex or mac). coversin is a recombinant small protein (16,740 da) derived from a native protein discovered in the saliva of the ornithodoros moubata tick, where it modulates the host immune system to allow the parasite to feed without alerting the host to its presence or provoking an immune response.

Компании с операционная прибыль похож на Akari Therapeutics Plc